Utilization of hepatitis C virus RNA-positive donor liver for transplant to hepatitis C virus RNA-negative recipient.
作者信息
Saberi Behnam, Hamilton James P, Durand Christine M, Li Zhiping, Philosophe Benjamin, Cameron Andrew M, Sulkowski Mark S, Gurakar Ahmet
机构信息
Division of Gastroenterology and Hepatology, The Johns Hopkins University School of Medicine, Baltimore, MD.
Division of Infectious Disease, The Johns Hopkins University, School of Medicine, Baltimore, MD.
出版信息
Liver Transpl. 2018 Jan;24(1):140-143. doi: 10.1002/lt.24838.
Abstract
摘要
相似文献
1
Utilization of hepatitis C virus RNA-positive donor liver for transplant to hepatitis C virus RNA-negative recipient.将丙型肝炎病毒RNA阳性供体肝脏用于移植给丙型肝炎病毒RNA阴性受体。
Liver Transpl. 2018 Jan;24(1):140-143. doi: 10.1002/lt.24838.
2
Hepatitis C genotype change after transplantation utilizing hepatitis C positive donor organs.使用丙型肝炎阳性供体器官进行移植后丙型肝炎病毒基因型的变化。
Transpl Infect Dis. 2018 Aug;20(4):e12925. doi: 10.1111/tid.12925. Epub 2018 Jun 13.
3
Should organs from hepatitis C-positive donors be used in hepatitis C-negative recipients for liver transplantation?丙型肝炎病毒阳性供者的器官是否应用于丙型肝炎病毒阴性受者的肝移植？
Liver Transpl. 2018 Jun;24(6):831-840. doi: 10.1002/lt.25072.
4
Hepatitis C-positive donor liver transplantation for hepatitis C seronegative recipients.丙型肝炎病毒阳性供体肝脏移植给丙型肝炎病毒血清学阴性受者。
Transpl Infect Dis. 2019 Dec;21(6):e13194. doi: 10.1111/tid.13194. Epub 2019 Oct 30.
5
Implications of Treating Hepatitis C Virus Infection Among Patients Awaiting Cadaveric Liver Transplant: A Single-Center Experience.等待尸体肝移植患者中丙型肝炎病毒感染治疗的影响：单中心经验
Exp Clin Transplant. 2015 Nov;13 Suppl 3:7-10. doi: 10.6002/ect.tdtd2015.L16.
6
Successful treatment of donor-derived hepatitis C viral infection in three transplant recipients from a donor at increased risk for bloodborne pathogens.成功治疗来自一名血源性病原体感染风险增加的供体的三名移植受者的供体源性丙型肝炎病毒感染。
Transpl Infect Dis. 2017 Apr;19(2). doi: 10.1111/tid.12660. Epub 2017 Feb 22.
7
Use of a hepatitis C virus (HCV) RNA-positive donor in a treated HCV RNA-negative liver transplant recipient.在接受治疗且丙型肝炎病毒（HCV）RNA呈阴性的肝移植受者中使用HCV RNA呈阳性的供体。
Transpl Infect Dis. 2018 Feb;20(1). doi: 10.1111/tid.12809. Epub 2018 Jan 3.
8
Maximizing donors with viral hepatitis in the current era.在当前时代最大化病毒性肝炎捐赠者。
Liver Transpl. 2017 Oct;23(S1):S44-S49. doi: 10.1002/lt.24863.
9
Liver Transplant From Increased-Risk Donors in the Era of Direct-Acting Antivirals for Hepatitis C.丙型肝炎直接作用抗病毒药物时代的高危供肝肝移植。
Exp Clin Transplant. 2020 Oct;18(5):605-611. doi: 10.6002/ect.2019.0065. Epub 2019 Jul 19.
10
Temporal Changes and Regional Variation in Acceptance of Hepatitis C Virus-Viremic Livers.慢性丙型肝炎病毒感染肝脏接受治疗的时间变化和地域差异
Liver Transpl. 2019 Dec;25(12):1800-1810. doi: 10.1002/lt.25644. Epub 2019 Oct 29.
引用本文的文献
1
Non-Standard Risk Donors and Risk of Donor-Derived Infections: From Evaluation to Therapeutic Management.非标准风险供者与供者源性感染风险：从评估到治疗管理。
Transpl Int. 2024 Oct 2;37:12803. doi: 10.3389/ti.2024.12803. eCollection 2024.
2
Expanding the liver donor pool worldwide with hepatitis C infected livers, is it the time?用丙型肝炎感染的肝脏扩大全球肝脏供体库，时机到了吗？
World J Transplant. 2024 Jun 18;14(2):90382. doi: 10.5500/wjt.v14.i2.90382.
3
Organ Utilization Rates from Non-Ideal Donors for Solid Organ Transplant in the United States.美国非理想供体用于实体器官移植的器官利用率
J Clin Med. 2024 May 31;13(11):3271. doi: 10.3390/jcm13113271.
4
The use of HCV positive donors among non-HCV infected liver transplant recipients.在非丙型肝炎病毒（HCV）感染的肝移植受者中使用HCV阳性供体。
Hepatol Forum. 2022 Jan 12;3(1):1-2. doi: 10.14744/hf.2021.2021.0048. eCollection 2022 Jan.
5
An Update on Usage of High-Risk Donors in Liver Transplantation.肝移植中高风险供体使用情况的最新进展
J Clin Med. 2021 Dec 31;11(1):215. doi: 10.3390/jcm11010215.
6
Treatment of Hepatitis C Post-Liver Transplantation Could Mitigate Discard Rates of Hepatitis C-Positive Deceased Donor Livers and Expand the Donor Pool.肝移植后丙型肝炎的治疗可降低丙型肝炎阳性脑死亡供肝的废弃率并扩大供肝库。
J Transplant. 2021 Jan 25;2021:6612453. doi: 10.1155/2021/6612453. eCollection 2021.
7
Donor Characteristics and Regional Differences in the Utilization of HCV-Positive Donors in Liver Transplantation.供者特征与肝移植中丙型肝炎病毒阳性供者利用的地域差异。
JAMA Netw Open. 2020 Dec 1;3(12):e2027551. doi: 10.1001/jamanetworkopen.2020.27551.
8
Cost-effectiveness of using hepatitis C viremic hearts for transplantation into HCV-negative recipients.使用丙型肝炎病毒血症心脏移植给 HCV 阴性受者的成本效益。
Am J Transplant. 2021 Feb;21(2):657-668. doi: 10.1111/ajt.16245. Epub 2020 Sep 15.
9
Update on Liver Transplantation: What is New Recently?肝移植最新进展：近期有哪些新情况？
Euroasian J Hepatogastroenterol. 2019 Jan-Jun;9(1):34-39. doi: 10.5005/jp-journals-10018-1293.
10
Immediate administration of antiviral therapy after transplantation of hepatitis C-infected livers into uninfected recipients: Implications for therapeutic planning.将丙型肝炎感染的肝脏移植给未感染的受者后立即给予抗病毒治疗：对治疗规划的影响。
Am J Transplant. 2020 Jun;20(6):1619-1628. doi: 10.1111/ajt.15768. Epub 2020 Feb 3.
本文引用的文献
1
The American Society of Transplantation Consensus Conference on the Use of Hepatitis C Viremic Donors in Solid Organ Transplantation.美国移植学会关于在实体器官移植中使用丙型肝炎病毒血症供体的共识会议。
Am J Transplant. 2017 Nov;17(11):2790-2802. doi: 10.1111/ajt.14381. Epub 2017 Jul 1.
2
Pre- Versus Posttransplant Treatment of Hepatitis C Virus With Direct-Acting Antivirals in Liver Transplant Recipients: More Issues to be Solved.肝移植受者中丙型肝炎病毒直接作用抗病毒药物的移植前与移植后治疗：更多待解决的问题
Exp Clin Transplant. 2017 Feb;15(Suppl 1):1-5. doi: 10.6002/ect.mesot2016.L19.
3
OPTN/SRTR 2015 Annual Data Report: Liver.器官获取与移植网络/器官共享联合网络2015年度数据报告：肝脏
Am J Transplant. 2017 Jan;17 Suppl 1:174-251. doi: 10.1111/ajt.14126.
4
Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus.丙型肝炎指南：美国肝病研究学会-美国感染病学会关于丙型肝炎病毒感染成人检测、管理及治疗的建议
Hepatology. 2015 Sep;62(3):932-54. doi: 10.1002/hep.27950. Epub 2015 Aug 4.
5
Liver allografts from hepatitis C positive donors can offer good outcomes in hepatitis C positive recipients: a US National Transplant Registry analysis.来自丙型肝炎阳性供体的肝移植可以为丙型肝炎阳性受者提供良好的结果：美国国家移植登记处分析。
Transpl Int. 2010 Oct;23(10):1038-44. doi: 10.1111/j.1432-2277.2010.01092.x.
Zotero 插件